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Abstract
Background: Polybasic cleavage sites of the hemagglutinin (HA) proteins are considered to be the most important
determinants indicating virulence of the avian influenza viruses (AIV). However, evidence is accumulating that these
sites alone are not sufficient to establish high pathogenicity. There need to exist other sites located on the HA
protein outside the cleavage site or on the other proteins expressed by AIV that contribute to the pathogenicity.
Results: We employed rule-based computational modeling to construct a map, with high statistical significance, of
amino acid (AA) residues associated to pathogenicity in 11 proteins of the H5 type viruses. We found potential markers
of pathogenicity in all of the 11 proteins expressed by the H5 type of AIV. AA mutations S-43HA1-D, D-83HA1-A in HA;
S-269-D, E-41-H in NA; S-48-N, K-212-N in NS1; V-166-A in M1; G-14-E in M2; K-77-R, S-377-N in NP; and Q-48-P in PB1-F2
were identified as having a potential to shift the pathogenicity from low to high. Our results suggest that the low
pathogenicity is common to most of the subtypes of the H5 AIV while the high pathogenicity is specific to each
subtype. The models were developed using public data and validated on new, unseen sequences.
Conclusions: Our models explicitly define a viral genetic background required for the virus to be highly pathogenic
and thus confirm the hypothesis of the presence of pathogenicity markers beyond the cleavage site.
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Background
Highly pathogenic avian influenza viruses (HPAIV) pose
a threat for yet another epidemic or pandemic, which
can potentially result in severe consequences for both
animal and human life. So far, only the low pathogenic
avian influenza viruses (LPAIV) of H5 and H7 serotypes
have been shown to be precursors for the HPAIV’s [1,
2]. To infect, the surface glycoprotein hemagglutinin
(HA) precursor, HA0, needs to be cleaved by cellular
proteases into functional HA1 and HA2 subunits [3].
LPAIV’s carry a monobasic cleavage site that is recog-
nized only by trypsin-like proteases [4, 3, 5] thus limiting
the infection to the respiratory and gastrointestinal
tracts [3, 5]. High pathogenicity has been previously
linked to insertions in the cleavage site of HA [6–8].
These insertions allow the HA0 to be cleaved by ubiqui-
tously expressed intracellular proteases such as furin [9–11]
leading to a systematic infection and lethal disease with
mortality rates being as high as 100 %. Recent studies
[12–14] have shown that the insertions in the cleavage
site of HA may not be sufficient to render the virus
highly pathogenic (HP). Although the cleavage site cer-
tainly is the most important virulence determinant, evi-
dence is accumulating that the HPAIV’s also carry
virulence determinants other than the polybasic cleav-
age sites in the HA protein [3, 5, 4]. Such determinants
may be located outside the cleavage site of the HA pro-
tein and spread across all the expressed proteins of the
virus creating a suitable environment for high patho-
genicity [3]. Since only H5 and H7 subtypes are known
to become HP and since there are too few HP se-
quences of the H7 subtypes for our analysis, we limited
our study to the analysis of H5 serotype of the AIV.
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We used publicly available protein sequence data for
all the proteins of H5 subtype of avian influenza viruses
(H5-AIV) [15]. Pathogenicity is very strongly linked to
the amino acid sequence of the cleavage site for natur-
ally occurring viruses [16] and thus aligned sequences of
the proteins were annotated with the pathogenicity value
(high or low) using the presence or absence of insertions
in the cleavage site of the corresponding HA protein, re-
spectively. The cleavage site was subsequently removed
from the HA protein sequences since we had already
used this information to label the sequences. This en-
ables learning other AA positions of the sequences that
may be related to the pathogenicity label. Ranking of the
pathogenicity significant AA positions for each of the
proteins was done with Monte Carlo Feature Selection
(MCFS) [17]. Rough set theory [18] as implemented by
ROSETTA [19] was applied in constructing rule-based
models of pathogenicity using the significant positions.
Such models are expressed as IF-THEN rules. See Fig. 1
for a schematic description of the method. The rules ex-
plicitly specified AA’s and their combinations that were
associated with the pathogenicity of the H5 subtype. In
addition to already known markers of pathogenicity, we
discovered other potential AA positions and mutations
that may affect the pathogenicity of H5-AIV. The
models were experimentally validated on new, unseen
sequences released after we built our models. Similar ap-
proaches to modeling that we used here have been suc-
cessfully applied to model many aspects of protein or
gene features such as, for instance, cleavability of
Fig. 1 Schematic representation of the applied computational modeling methodology
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octamer peptides by HIV-1 protease [20], drug resist-
ance [21], binding affinities [22] and participation in bio-
logical processes [23].
To the best of our knowledge this work is the first
proteome-wide characterization of the pathogenicity
landscape of the H5 subtype of avian influenza viruses
based on all available sequences to date.
Results
High quality predictive models of pathogenicity for all
proteins
Following MCFS that identified AA positions significant
in discriminating high from low pathogenic (LP) sequences
(Table 1, Additional file 1: Table S1 and Additional file 2:
MCFS_output.xlsx), we constructed high quality predictive
models of pathogenicity of the H5 viruses expressed in the
form of IF-THEN rules. Application of MCFS was essential
in processing this high dimensional data and provided
ranking of the importance of the AA positions with respect
to discriminating pathogenicity. ROSETTA was applied to
construct rule-based models for each of the proteins using
the significant features as selected by MCFS as described
in Material and Methods.
The model for the HA protein, with the cleavage site
removed, was the best one with 98.6 % accuracy and
1.1 % standard deviation, while the models for the other
proteins had accuracies in the range 81.2–97.2 %, with
the least accurate model for the NP protein (Fig. 2a).
Extraction of significant rules from the models
For the HA protein the set of significant rules (p < 0.05;
hyper-geometric distribution; Bonferroni-corrected p-value)
consisted of 138 rules for high pathogenicity and 65 rules
for low pathogenicity. Similarly, for the NA protein we ob-
tained 11 rules for high pathogenicity and 59 for low patho-
genicity. The sets of significant rules are referred to as
classifiers in our study. The classifiers for all the proteins
are listed in Additional file 3: Classifiers.xlsx.
High pathogenicity rules in the classifiers were highly
accurate for the H5N1 subtype sequences
Since the HP training sequences were predominantly of
the H5N1 subtype (Table 1) (e.g. HA had 1377 H5N1 se-
quences out of 1425), we suspected that the rules for high
pathogenicity would predominantly be learning H5N1
pathogenicity. This hypothesis was confirmed through re-
classification of the training sequences by the classifiers.
For the HA protein, 1374 of the 1377 H5N1 HP sequences
were correctly re-classified as HP, and 52 of the 54 H5N1
LP sequences were correctly re-classified as LP. From the
total of 48 HP sequences of the non-H5N1 subtypes, we
could only correctly re-classify 24 sequences. However,
511 of the 512 non-H5N1 LP sequences were re-classified
correctly (Fig. 2b and c, Additional file 4: Table S2-S3).
For the NA protein, all of the 551 H5N1 HP sequences
were classified correctly as HP and all 32 of the 32 H5N1
LP sequences were also classified correctly. None of the
23 non-H5N1 HP sequences were correctly classified,
while all of the 264 non-H5N1 LP sequences were cor-
rectly classified. The numbers for the remainder of the
proteins are shown in Fig. 2b and c (see also Additional
file 4: Table S2-S3).
Validation of classifiers on new, unseen sequences
Our classifiers were generated using data published on
23 January 2014. We validated our classifiers by classify-
ing new, unseen sequences published after that date.
Only unique sequences were considered, i.e., sequences
identical to the sequences used in learning the models
were removed. The cleavage site in these new sequences
was removed prior to classification.
For the H5N1 subtype sequences, the HA rules per-
formed with accuracy of 99.3 % classifying 134 of 135 se-
quences correctly (Fig. 2d, Additional file 5: Table S4).
Rules from the NA models classified all of the 108 se-
quences correctly i.e. accuracy 100 %. Rules from M1,
NS1, NS2, PB1, PB1-F2 and PB2 gave a perfect classifi-
cation of the sequences i.e. accuracy was 100 %. M2
rules classified 47 of 49 sequences correctly and NP
rules classified 42 of 44 sequences correctly. Rules from
the PA models were the least accurate with 85.4 % ac-
curacy by correctly classifying 39 of 45 sequences.
The non-H5N1 type HP sequences were mostly of the
H5N8 subtype (HA: 43 of 48, NA: 43 of 44, M1: 42 of
43, M2: 41 of 42, NS1: 43 of 45, NS2: 43 of 45, NP: 43 of
46, PA: 43 of 45, PB1: 43 of 45, PB2: 43 of 46, PB1-F2:
40 of 41) (Fig. 2e, Additional file 5: Table S5).
Table 1 The training data
Protein H5N1 Non-H5N1 Total All
Features
Significant
FeaturesHP LP HP LP HP LP
HA 1377 54 48 512 1425 566 616 82
NA 551 32 23 264 574 296 593 114
M1 161 9 13 52 174 61 329 16
M2 186 9 14 63 200 72 98 18
NS1 425 16 22 148 447 164 249 71
NS2 202 3 14 53 216 56 129 25
NP 294 12 22 113 316 125 511 22
PA 465 22 25 235 490 257 730 57
PB1 405 26 25 223 430 249 775 44
PB2 446 26 23 247 469 273 783 62
PB1-F2 135 16 15 114 150 130 101 40
The HP and LP columns represent the number of highly pathogenic and low
pathogenic sequences in each of the proteins, respectively. The ‘All features’
column is the total number of features (i.e. AA’s) from which significant
features are selected with Monte Carlo Feature Selection
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Interestingly, the classifiers for HA, M1, M2 and PB1
proteins gave a perfect classification (100 % accuracy)
for the respective protein sequences. 45 of 46 new PA
sequences were also correctly classified. On the other
hand only two of the 45 for NS1 and NS2 sequences
each, three of the 46 NP sequences, two of 46 PB2 se-
quences and 1 of 41 PB1-F2 sequences could be classi-
fied correctly with our classifiers. It suggests that the
pathogenicity markers carried by these new H5N8 se-
quences in the HA, M1, M2, PB1 and PA protein are
similar to the ones for the H5N1 subtypes.
Amino acids and their combinations associated with
pathogenicity
Filtering for the strongest rules (Accuracy ≥ 80 % and
Class-Specific-Coverage ≥ 50 %) in the HA classifier pro-
duced three rules for high pathogenicity and 13 for low
pathogenicity (Table 2). The HP HA rules associated D-
43HA1, A-83HA1 and I-71HA1 with high pathogenicity.
The LP-rules associated S-43HA1, D-83HA1, S-107HA1,
N-138HA1, D-309HA1, V-302HA1, A-7SP, I-6SP, D-275HA1,
N-195HA1, S-240HA1, R-3SP and S-194HA1 with low
pathogenicity, where HA1 and HA2 are the two subunits
Fig. 2 Accuracies of the cross-validation and the testing of the models on new, unseen data. a Quality measures for the rule-based models. Averaged
Accuracy is the average of mean accuracy from the 10-fold cross-validation loop for the models created on 100 under-sampled subsets for
each protein. Standard deviation from the 10-fold cross validation loop, averaged in a similar way as accuracy, is shown as error bars on the
plot. b Re-classification of the training sequences of the H5N1 sequences. Accuracy is the percentage of correctly classified sequences. See also
Additional file 4: Table S2. c Re-classification of the training sequences of the non-H5N1 sequences. Accuracy is the percentage of correctly
classified sequences. See also Additional file 4: Table S3. d Accuracies of the classifiers when tested on the newly published unseen H5N1
sequences, i.e. sequences not included in the training of the models and with sequences identical to the training sequences removed. Accuracy is
the percentage of correctly classified sequences. Classifiers consisted of the significant rules from all the rule-based models created for a given protein.
See also Additional file 5: Table S4. e Accuracies of the classifiers when tested on the newly published unseen non-H5N1 sequences, i.e. sequences not
included in the training of the models and with sequences identical to the training sequences removed. Accuracy is the percentage of correctly
classified sequences. Classifiers consisted of the significant rules from all the rule-based models created for a given protein. See also Additional file 5:
Table S5
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of HA and SP is the signal peptide of the non-cleaved
sequence. For the NA protein, from the strongest rules
(Additional file 6: Table S6), AA residues N-369, G-386,
T-288, D-269, H-41 and H-100 were associated with
high pathogenicity and N-400, K-38, V-192, P-90, I-73,
I-262, L-255, M-24, S-14, E-41, S-269, K-187, T-434, E-
74 and S-43 were associated with low pathogenicity. The
strongest rules for the other proteins are shown in Add-
itional file 6: Table S7-S16. AA’s and their combinations
associated with high and low pathogenicity, respectively,
for all the proteins are summarized in Table 3.
AA mutations associated with the shift of pathogenicity
from low to high
To associate AA mutations with a shift in pathogenicity
from low to high we compared the strongest HP and LP
rules that have the same position but a different residue.
There were two such cases in the strongest HA rules.
For the HA protein, all the LP rules that specified pos-
ition 43HA1 had a Serine residue and the HP rules with
position 43HA1 had an Aspartic acid residue there.
Hence, the mutation S-43HA1-D was associated with a
shift in pathogenicity from low to high. Similarly, muta-
tion D-83HA1-A was also associated with a pathogenicity
shift from low to high. By the same token, mutations S-
269-D, E-41-H in the NA protein, S-48-N, K-212-N in
the NS1 protein, V-166-A in the M1 protein, G-14-E in
the M2 protein, K-77-R, S-377-N in the NP protein and
Q-48-P in the PB1-F2 protein (Table 4) were associated
with shifts of pathogenicity from low to high.
Analysis of the AA alterations involved in the strongest
rules
An analysis of AA positions in the rules associated to
pathogenicity (Table 3) produced the following results.
HA rules
AA residues at positions 138 and 212 appearing in the
LP rules and AA residue at position 108, adjacent to
position 107 from our rules, have previously been linked
with pathogenicity [24]. AA residue at position 320HA1,
appearing in the LP rules, is a residue flanking the cleav-
age site on one side and is also shown previously to
affect pathogenicity [25]. AA residues at positions 42HA1
and 274HA1, which are adjacent to residues at positions
43HA1 and 275HA1 appearing in our rules, make a di-
sulfide bond (UniProt: O56140). AA positions from the
strongest rules for HA are shown in Fig. 3a.
NA rules
Position 369 appearing in the HP rules lays close to
position 371 of the active site of the protein as shown
in Fig. 3b. Positions 369, 288, 386, 269, 400, 434 and
187 are on the surface of the protein (Fig. 3b). Position
100 is in the region that is in contact with chain B of
the NA tetramer. AA residue at position 400 from the
LP rules is close to a potential glycosylation site at pos-
ition 402 [26].
NP rules
Positions 377, 482, 373 and 450 appears in the PB2
interaction domain (AA 340–498) of NP [27]. More spe-
cifically, position 482 is found in the last 33 amino acids
of NP that regulate the NP-PB2 binding [27]. Positions
34 and 77 are in a domain that is characterized as RNA
binding sub-region (AA 1–77) [28] and PB2 interaction
Table 2 The strongest rules for highly and low pathogenic
viruses from the HA classifier
Rule Accuracy (%) Support Class-Specific-
Coverage (%)
HP-Rules IF P43(HA1) = D
THEN virus = HP
99.8 1225 86
IF P83(HA1) = A
THEN virus = HP
100.0 807 57
IF P71(HA1) = I
THEN virus = HP
100.0 759 53
LP-Rules IF P43(HA1) = S
THEN virus = LP
95.2 589 99
IF P83(HA1) = D
THEN virus = LP
94.6 571 95
IF P107(HA1) = S
THEN virus = LP
95.8 552 93
IF P138(HA1) = N
THEN virus = LP
92.7 536 88
IF P309(HA1) = D
THEN virus = LP
94.9 533 89
IF P320(HA1) = V
THEN virus = LP
95.7 532 90
IF P195(HA1) = N
THEN virus = LP
88.8 400 63
IF P16(SP) = G
THEN virus = LP
89.3 392 62
IF P203(HA2) = I
THEN virus = LP
82.4 380 55
IF P6(SP) = I THEN
virus = LP
97.5 354 61
IF P7(SP) = A
THEN virus = LP
98.0 352 61
IF P3(SP) = R
THEN virus = LP
94.1 341 57
IF P240(HA1) = S
THEN virus = LP
95.2 332 56
IF P275(HA1) = D
THEN virus = LP
97.3 300 52
Accuracy is the percentage of the sequences in the support set correctly
classified by the rule. Support is the number of sequences that satisfy the
“IF” conditions of the rule. Class-Specific-Coverage is the percentage per class
(i.e. HP or LP, respectively) of the sequences that support the rule and are
correctly classified by the rule. For instance, if a rule is an HP class rule then
the Class-Specific-Coverage gives the percentage of the HP sequences classified
correctly by this rule
Khaliq et al. BMC Microbiology  (2015) 15:128 Page 5 of 13
domain (AA 1–161) [27]. Position 34 occurring in the
HP rules has previously been shown to be a determinant
of temperature sensitivity [29]. All the positions in the
rules were on the surface of the protein (Fig. 3c).
NS1 rules
AA residue at position 48 from the HP rules lays next to
position 49, which has been shown to be involved in
RNA binding [30]. AA residue at position 212 occurs in
Table 3 AA’s and its combinations associated with high and low pathogenicity in all the proteins
Association to high pathogenicity Association to low pathogenicity
Singular residues Combination
of residues
Singular residues Combination of residues
HA D-43HA1, A-83HA1, I-71HA1 - S-43HA1, D-83HA1, S-107HA1, N-138HA1,
D-309HA1, V-302HA1, A-7sp, I-6sp, D-275HA1,
N-195HA1, S-240HA1, R-3SP, S-194HA1
-
NA N-369, G-386, T-288, H-100, D-269, H-41 - N-400, K-38, V-192, P-90, I-73, I-262, L-255,
M-24, S-14, E-41, S-269, K-187, T-434, E-74, S-43
-
NS1 N-48, L-207, N-212 R-59 & N-212, M-27 P-208 & K-212,
F-22 & N-48 S-82 & R-113 & D-166,
F-22 & S-82 & T-89 & R-113,
P55 = E & P73 = S & P82 = S
& P89 = T & P113 = R
S-48 & S-73 & S-82 & D-166,
S-48 & S-82 & D-166,
S-82 & A-107 & R-113,
S-73 & S-82 & R-113,
S-82 & R-113,
S-82 & K-212
NS2 A-22, A-115, V-14 V-6 & I-60 - V-49 & S-60
M1 A-166, N-232, N-224, K-27, I-168 T-121 & I-168 V-166, R-101 V-166 & D-232
M2 E-14 - - G-14 & E-66,
G-14 & I-28,
G-14 & K-18,
I-28 & S-82,
K-18 & I-28
NP S-34 N-377 & N-482, N-450 K-77 & V-353 & S-377
S-34 & N-377,
S-34 & N-482,
R-77 & N-482,
R-77 & N-377,
A-373 & S-450,
A-373 & N-377
PA T-129, S-58 - - -
PB1 I-149, V-14, L-384 I-113 & I-149, - A-14 & V-113 & G-154 & S-3
V-14 & I-113,
I-113 & K-386,
T-59 & 113-I & K-215,
I-113 & K215
PB2 M-64, T-339 - I-478 M-64 & I-478
PB1-F2 Y-57, P-48 - Q-48, D-50 -
AA’s for the HA protein are shown to be either of HA1, HA2 or Signal Peptide (SP). AA’s for the NA protein shown are numbered according to the whole length
sequences i.e. the sequences without the stalk deletion
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the binding site of the adapter protein Crk/CrkL-SH3
domain [31]. Residues at positions 207 from the HP
rules and 208 from the LP rules occur in an unstruc-
tured and flexible tail region which contains a number
of motifs including Crk/CrkL-SH3 binding and PDZ lig-
and [32]. Residues at position 82 and 113 from the LP
rules are positioned at the ends of the eIF4G1-binding
domain [33], which stretches from residue 81–113. Pos-
ition 89 of the NS1 protein appearing in the LP rules has
been shown to be one of the residues on NS1 protein
where p85β, a regulatory subunit of phosphatidylinositol-
3-kinase (PI3K), binds [34]. AA residue at position 107 is
adjacent to 106, which has been shown to affect the repli-
cation rate in mammalian cells [35]. Positions from the
strongest rules are shown in Fig. 3d.
NS2 rules
Position 22, appearing in the strongest HP rules for the
NS2 protein, is positioned at the end of the nuclear export
signal motif while position 14 is inside it, which stretches
from 12 to 21 (UniProt: O56263). Position 49 in the stron-
gest HP rules is near position 47, which has been previ-
ously reported to be related to pathogenicity [36].
M1 rules
Positions 166, 232, 224 and 168 appearing in the HP rules
are in the C-terminal domain that binds to viral RNP [37]
while position 121 is in a lipid binding site [37].
M2 rules
Position 14 appearing in M2 rules is adjacent to a con-
served W-15 residue in a highly mutable region (aa10-20)
of the M2 extracellular domain [38]. Position 18, in the LP
rules, is situated in the M2 extracellular domain. The AA
residue at position 28 is adjacent to position 27, which has
been shown in H3 and H1 subtypes to be associated with
adamantane resistance [39, 40].
PA rules
Positions 58 and 129 appearing in our rules are part of
the N-terminus region of PA, which is considered to
be the most active part of the protein. Position 58 is
next to position 57, which has been shown to be in-
volved in suppressing the host protein synthesis during
infection [41].
PB1 rules
Position 14 is in the PA binding domain (AA 1–25) of
the PB1 protein [42]. It is next to position 13, which is
considered to be a determinant of the host range for
AIV’s [43]. Position 215 is situated in the nuclear
localization motif (AA 203–216) and positions 384 and
386 are found in the catalytic domain of the protein
(UniProt-Q9Q0V0).
PB2 rules
Position 64, next to position 63, from our rules has been
shown to be a determinant of pathogenicity [44]. Pos-
ition 339 is in the cap-binding domain AA 318–483
(Fig. 3e) [45]. Interestingly, our rules use position 627.
Previously, mutation E-627-K has been shown to in-
crease pathogenicity [46]. However, it occurred in only
18 % of the HP sequences of this study and consequently
was not selected to be sufficiently significant by our
Class-Specific-Coverage filtering that was set for all the
rules to be at least 50 % (see Experimental Procedures).
PB1-F2 rules
Position 57 is next to position 56 that has been shown
to affect pathogenicity in H5N1 mallard ducks [47].
Discussion
The goal of this study was to identify AA’s and their
combinations other than the cleavage site of the HA
protein that have the potential to affect the pathogen-
icity of the H5 subtype of AIV. Another goal was to as-
sociate specific AA changes or mutations with a shift of
pathogenicity from low to high. To this end, mathemat-
ical modeling using known methods of Monte Carlo
Feature Selection and rough sets were applied to all the
viral proteins. Sets of statistically significant rules were
extracted from the models and called classifiers. Valid-
ation of the classifiers performed on new, unseen se-
quences, i.e. sequences published after we extracted the
data for our analysis, showed that the model was indeed
very highly predictive for at least the period of
10 months, i.e. between January and October 2014.
Among the identified positions, the most interesting
seemed to be the ones that defined mutations associated
Table 4 AA mutations associated with a shift of pathogenicity
from low to high
AA mutations associated with a change in
pathogenicity from low to high
HA S-43HA1-D, D-83HA1-A
NA S-269-D, E-41-H
NS1 S-48-N, K-212-N
NS2 -
M1 V-166-A
M2 G-14-E
NP K-77-R, S-377-N
PA -
PB1 -
PB2 -
PB1-F2 Q-48-P
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with the shift from LP to HP in several of the proteins.
The positions and their residue values defined the gen-
etic background of the AIV necessary to produce a high
pathogenicity as defined by the characteristics of the HA
cleavage site. This finding was consistent with the idea
of pathogenicity markers outside the cleavage site of the
HA protein [13, 3, 14, 5, 12, 4].
The results of re-classification showed that the rules of
the classifiers for high pathogenicity were able to cor-
rectly and with very high accuracy classify H5N1 HP
A B
C
D
E
Fig. 3 AA’s appearing in the most significant rules marked on the 3D structures of different proteins. AA residues appearing in the rules are
shown as spheres. Positions from the high pathogenicity rules are shown in blue, positions from the low pathogenicity rules are in magenta and
mutations associated with the shift of pathogenicity from low to high as defined by the rules are shown in red. a Mapping of amino acid positions
associated with pathogenicity from the rules onto 3D structure of the HA protein of Influenza A virus (A/Hubei/1/2010 (H5N1)) (PDB: 4KTH). Chain A (HA1
residues) and chain B (HA2 residues) are presented in green, while the rest of the trimer is shown in gray. b A cartoon representation of chains A, B, C
and D of the NA protein with AA positions from the rules (PDBID: 2HU4). Chain A, the one marked with rule positions, is shown in green and the others
in gray. Residue R-371, shown as a sphere in orange, is a part of the catalytic site of the protein. Cyan spheres constitute Oseltamivir 2, a substrate bound
to the protein. c A cartoon representation of the NP protein trimer (PDBID: 2IQH) with positions from the rules. Chain A is shown in green and the others
are in gray. d AA’s from the rules marked on a cartoon representation of NS1 (PDBID: 3FST). e A cartoon representation of the PB2 protein cap-binding
domain (PDBID: 4CB4) with AA’s from the rules
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sequences, while non-H5N1 HP sequences were classi-
fied poorly. However, regardless of the subtype, the re-
classification of all LP sequences was done with high ac-
curacy although the prevalence of H5N1 LP was low, as
opposed to the prevalence of non-H5N1 LP sequences.
This suggests that the mechanism of low pathogenicity
is similar in all H5 type sequences, while the mechanism
of high pathogenicity of H5N1 is specific to this subtype.
Furthermore, it is interesting to notice that the new
non-H5N1 HP sequences were mostly of the H5N8 sub-
type that caused outbreaks in South Korea earlier this
year [48]. Following genetic analysis, this reassortant
virus is thought to have borrowed HA, PB2 and NP seg-
ments from H5N1-like viruses, PB1, PA, M and NS seg-
ment from H4N2-like viruses, and NA from the
previous H5N8-like avian influenza viruses [48]. We ob-
served a perfect classification by the models of HA, M1,
M2, PB1 and PA but poor classification by the rest of
the models. Notably, the PB2 and NP protein models
performed poorly even though these segments are
thought to be contributed by H5N1-like viruses with
which we trained the models. This may suggest that the
PB2 and NP segments have adapted to H5N8-specific
highly pathogenic viral background. The perfect classifi-
cation of the M1, M2, PB1 and PA models, despite them
being contributed by H4N2-like viruses, suggests that
the markers of high pathogenicity in these proteins are
similar to the H5N1 type markers. It would follow that
the viral background necessary for high pathogenicity in
the new H5N8 viruses is partly (i.e. in HA, PA, PB1, M1
and M2 proteins) similar to that of the H5N1-like vi-
ruses. Nevertheless, the fact that this background differs
in the NS1, NS2, PB2, PB1-F2, NP and NA proteins sup-
ports our conclusion that the markers of high pathogen-
icity are subtype specific.
A survey of the AA’s, which have been shown to be
important for the H5 pathogenicity in previous studies,
suggests that our methods pinpoint biologically relevant
locations in various viral proteins. Our positions were,
among others, in the immediate neighborhood of posi-
tions that have been indicated previously, in the vicinity
of active sites of the proteins and in a few cases were a
direct hit of a position that have been described earlier
as important for pathogenicity. However, since most of
the published results have not been done in the context
of pathogenicity the comparisons needs to be treated
with caution. To the best of our knowledge, our findings
are the first ones to be based on a large number of avail-
able sequence data and are statistically significant.
However, it eventually will be necessary to confirm
these findings experimentally not only by testing them
on new, unseen sequences, but also by testing specific
combinations of mutations to find out minimal sets that
induce high pathogenicity. Our computational work
clearly shows where to search and makes this search
plausible by a dramatic restriction to a manageable num-
ber of cases. Further studies of the particular roles of
these novel markers outside the polybasic cleavage site
of the HA protein, and on the other proteins, as well as
the roles of activating proteases in various hosts, affect-
ing these newly detected marker sites, will be required.
Conclusions
We used sequences of all 11 proteins of the avian influenza
A virus to build high quality and easy to read IF-THEN
rule-based models of pathogenicity for each protein. From
the rules we extracted a map of markers of both high and
low pathogenicity in all the proteins. Our models were able
to correctly predict low pathogenicity independently of the
NA subtype indicating that low pathogenicity was com-
mon to all H5 viruses irrespectively of NA type. The same
was not true for high pathogenicity where we could only
correctly classify the HP H5N1 sequences with high accur-
acies (100 % for some proteins) but not the HP non-H5N1
sequences. Surprisingly, the pathogenicity of the new and
unseen H5N8 subtype sequences, that are currently circu-
lating, could be perfectly predicted with the H5N1 models
of HA, M1, M2, PA and PB1 and poorly with the models
for the other proteins. This suggests that the pathogenicity
markers of the H5N8-like viruses are similar to H5N1-like
viruses in these proteins but different from H5N1-like
viruses in the rest of the proteins. In summary, we
identified a viral background for the H5N1 type viruses
that, in addition to the previously known insertions in
the cleavage site of the hemagglutinin protein, seems to
be necessary for a virus to become highly pathogenic.
This study narrows down the possible combinatorial
space for pathogenicity analysis and provides a platform
for further analysis and biological verification of the
discovered pathogenicity markers. The detection and
identification of the additional sites and factors of viru-
lence alteration in the viral genomes provide basic
novel information for the i) better understanding of
viral evolution; ii) for the improvement of diagnosis; iii)
and for the development of more effective vaccine can-
didates and other measures to control the devastating
diseases caused by AIV all over the world.
Methods
Amino acid sequences and their alignment
The data was downloaded from the NCBI Influenza
Virus Resource database [15] in January 2014 as FASTA
files. It contained unique AA sequences from the 11
AIV proteins: HA, NA, M1, M2, NS1, NS2, NP, PA,
PB1, PB2 and PB1-F2. To download the HA sequences,
we filled the form at the NCBI’s influenza resource
download page as follows:
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 Type: A
 Host: Avian
 Country/Region: any
 Protein: HA
 Subtype: H: any N: any
 Full length plus: checked
 Collapse identical sequences: checked
The “collapse identical sequences” option guaranteed
we did not have identical sequences in our data sets. All
the other sequences for the other proteins were also
downloaded with the same settings. At this point the
data contained all subtypes. The downloaded amino acid
sequences were aligned using MUSCLE (v3.8.31) [49],
for each protein separately. These aligned sequences
were used to create decision tables. The H5-type se-
quences were then extracted from the decision tables as
described in the next section.
Annotation and extraction of data of interest
For each protein, the data was organized into a decision
table: the first column contained the identifiers of the
AA sequences, the following columns represented posi-
tions and contained the corresponding AA’s with the last
column to contain the outcome, i.e. the pathogenicity
label 1 or 0, where 1 labeled a highly pathogenic (HP)
sequence and 0 a low pathogenic (LP) one, respectively.
Gaps in the alignment were represented by a ‘?’ in the
decision tables. The rows of a decision table are called
objects, while columns other than the first and the last
one are called features.
Pathogenicity is very strongly linked to the amino acid
sequence of the cleavage site for naturally occurring vi-
ruses [16]. For a sequence to be labeled as HP, two cri-
teria must be met; 1) There is an elongation of the
cleavage site, i.e. an insertion of one or more AA’s in the
cleavage site; 2) The last 4 AA’s of the cleavage site must
be of the form (R/K)XX(R/K) [16].
Since the pathogenicity values were not present in the
NCBI database, we labeled each sequence according to
the criteria as defined above. Sequences with no corre-
sponding HA sequence information could not be labeled
and were not included in the analysis. Importantly, the
sequence corresponding to the cleavage sites in the HA
protein was removed prior to further analysis. From the
decision tables, we extracted AA sequences belonging to
the H5 serotype.
Feature selection
To remove noise from the data and to select only the
features that contributed significantly towards discerning
high from low pathogenicity, Monte Carlo Feature Selec-
tion (MCFS) was used as described in [17], which is im-
plemented in dmLab [50]. MCFS uses a very large
number of decision trees to assess the contribution of
features (AA positions) towards the outcome (HP/LP).
MCFS computes a normalized relative importance (RI-
norm) score for each feature. Statistical significance of
the RI-norm scores was assessed with a permutation test
and significant features (p < 0.05), after Bonferroni cor-
rection [51], were kept as described in [52]. Only these
significant features were used in the further mathemat-
ical model generation.
Rough sets and rule-based model generation
Rough set theory [18] was used as the basis for mathem-
atical modeling. Rough sets produced minimal sets of
features that can discern between the objects belonging
to different decision classes. The final representation of
the discernibility is in the form of IF-THEN rules. RO-
SETTA [19], a publicly available software system [53]
(http://www.lcb.uu.se/tools/rosetta/) that implements
rough sets theory, was used to build rule-based models.
A complete description of rough sets can be found in
[54] and the combined MCFS-ROSETTA approach to
model generation in bioinformatics is described in [55].
The input data to ROSETTA were decision tables con-
taining the viral sequences using only the significant fea-
tures that were from feature selection. ROSETTA
computed approximately minimal subsets of feature com-
binations that discern between the outcomes HP and LP.
The classifiers were collections of IF-THEN rules that were
inferred from the labeled AA sequences. A sample rule
reads: “IF at position 22 there is a Phenylalanine residue
AND at position 48 there is an Asparagine residue THEN
the virus is highly pathogenic”.
There is additional information about the rules avail-
able, too. For this rule, Accuracy is 99.7 %, that is the
proportion of true positives and true negatives to the
sum of true positives, true negatives, false positives and
false negatives is 0.997. Support is the set of sequences
(355 sequences) that satisfy the conditions of the left
hand side (LHS), i.e. the set of sequences that have a
Phenylalanine residue at position 22 and an Asparagine
residue at position 48. The above rule is a conjunctive
rule since there is a conjunction of conditions (P22 = F
AND P48 = N) in the left hand side (LHS) of the rule. A
rule can also be a singleton rule where LHS consists of
only a single condition.
In the data for all the proteins, the number of HP and
LP sequences differed significantly in favor of the HP se-
quences. This imbalance would affect the learning
Rule Accuracy (%) Support
IF P22 = F AND P48 = N THEN virus = HP 99.7 355
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process in favor of the class having more objects [56].
One of the solutions to this problem was to balance the
classes [57]. To address this problem a technique called
under-sampling was used. The set of all HP objects was
sampled randomly to create 100 subsets, where the
number of HP sequences was equal to the number of LP
sequences effectively producing balanced data sets. A
single rule-based model was inferred from each of the
subsets, which resulted in 100 models per protein. We
illustrate the process with the following example.
The data set of the HA protein had 1425 HP and 566
LP sequences, which was a significant imbalance in the
number of sequences. From the HP set we created sub-
sets by randomly extracting 100 times 566 HP objects
and joining them with the 566 LP objects to create 100
subsets. A rule-based model was inferred from each of
the subsets. To assess the performance of the models, a
10-fold cross validation was performed for each of them.
Mean accuracy and accuracy standard deviation were
calculated for all the models. For each protein the aver-
age of the accuracies and standard deviations for the 100
models served as the quality assessment criteria for our
rule-based models.
Filtering the most significant rules (classifiers) from all the
models for a protein
Significant rules (p < 0.05; hyper-geometric distribution;
Bonferroni-corrected p-value, as described previously)
were filtered from the 100 models. These rules were
called classifiers.
Validation of the classifiers
In order to validate our models on new, unseen data, we
downloaded H5N1 type AA sequences for each protein
from the NCBI website [15] that were made available
after we constructed our models. These sequences were
classified with our classifiers.
Extraction of the strongest rules from our classifiers
To extract the strongest rules from each classifier, for
each of the significant rule in the classifiers we calcu-
lated Class-Specific-Coverage, which was the percentage
of correctly classified viral sequences in the HP and LP
class, respectively, according to the formula:
Class−Specific−Coverage ¼ Accuracy Supportð Þ
TotalSequences
 100
Support is the number sequences that satisfy the LHS
conditions of the rule, as described earlier, and Accuracy
is the accuracy of the rule.
If the rule for which we intended to calculate Class-
Specific-Coverage was for the HP class then TotalSe-
quences was the total number of the HP sequences and
if the rule was for the LP class then it was the total num-
ber of the LP sequences. After calculating Class-Specific-
Coverage for all the rules in a classifier for each protein,
we extracted rules that had Accuracy of at least 80 %
and Class-Specific-Coverage of at least 50 %.
From alignment positions to true positions
The AA positions occurring in rules of our classifiers for
all the proteins were corresponding to the positions
coming from their respective multiple alignments. In
order to compare the AA’s occurring in our rules to the
ones that have already been discussed in literature, we
needed to obtain the true positions. A true position in a
single sequence would be the position without counting
the alignment gaps. For each AA position occurring in
the rules in our classifiers, for all proteins, we identified
its corresponding true position. This was achieved as fol-
lows. We took an AA position appearing in rules from a
classifier and identified its corresponding true position
in each of the training sequence used to infer the classi-
fier. The position to which our alignment position
mapped in most of sequences was taken to be the true
position. For example, to obtain the corresponding true
position for position 169 (alignment position) in the
rules for the M1 protein, we found that it corresponded
to position 166 in 226 sequences and position 165 in
nine sequences. Hence we said alignment position 169
of the M1 protein corresponds to true position 166.
Positions 1–16 of HA were labeled as signal peptide
(SP) positions. Positions 17–336 were labeled as HA1
subunit positions and the remaining positions were la-
beled as positions of the HA2 subunit. For the HA pro-
tein we showed true positions for each subunit,
respectively. For example, true position 2HA1 corre-
sponded to true position 18 of the HA and true posi-
tions 2HA2 corresponded to true position 338 after the
cleavage site is removed from the sequence.
For the NA protein we showed rules with AA posi-
tions for the full-length protein (without deletion in its
stalk region). In the Additional file 6: Table S16 we also
provided rules with positions for the NA protein that
has a deletion in its stalk region.
Classification of an AA sequence
For a given AA sequence, all the rules with conditions
matching the sequence are called to fire for the se-
quence. Each rule has a decision class in the THEN-part.
The firing rule is called to vote for the decision. The
number of votes is equal to the support set of the rule.
All the votes of all the firing rules are summed up per
class and the majority wins. As a sample application
consider a sequence MALAMTRS and the following
(hypothetical) classifier with 5 rules:
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1. IF P3 = L THEN virus = HP, Support = 16
2. IF P4 = A AND P7 = R THEN virus =HP, Support = 10
3. IF P6 = K AND P7 = R THEN virus =HP, Support = 7
4. IF P3 = S THEN virus = LP, Support = 12
5. IF P5 =M AND P8 = S THEN virus = LP, Support = 6
Rules 1, 2 and 5 fire for the sequence casting 16, 10
and 6 votes, respectively, resulting in 26 votes for class
HP and 6 votes for class LP. Rules 3 and 4 do not fire
and are not considered any further. The majority of
votes is for HP and the classifier thus determines the se-
quence to belong to this class. Clearly, the AND in the
condition of a rule means that all the conjuncts must be
satisfied in order for the rule to fire. It is also important
to note that a single rule by itself cannot be used to infer
pathogenicity. Classification is obtained only by an appli-
cation of all rules of the classifier.
Furthermore, if the conditions of a rule are not met
for a sequence, it cannot be inferred that the sequence
belongs to the other class or classes than the one given
by the THEN-part. It further follows that rules provide
only positive evidence. If there is no rule in the classifier
that would fire for a given sequence, its virulence status
remains unknown.
Scripting programming language
Python programming language was used for scripting
purposes.
Additional files
Additional file 1: Table S1. A table showing the top 20 features
selection by the feature selection for HA protein.
Additional file 2: Spreadsheet that contains the MCFS output for all
the proteins.
Additional file 3: Spreadsheet containing complete classifiers for all
the proteins.
Additional file 4: Contains Table S2 and Table S3 that show the
performance of re-classification of the training data.
Additional file 5: Contains Table S4-S5 showing the performance of
our models of new, unseen H5N1 and non-H5N1 type sequences.
Additional file 6: Contains Table S6-S16 that shows the strongest
rules from the classifiers of the proteins other than HA.
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